Synthesis of chalcone-imide derivatives and investigation of their anticancer and antimicrobial activities, carbonic anhydrase and acetylcholinesterase enzymes inhibition profiles

The new 1-(4-(3-(aryl)acryloyl)phenyl)-1H-pyrrole-2,5-diones (5a-g) were prepared from 4′-aminchalcones (3a-g) and screened for biological activities. All compounds (3a-g and 5a-g), except 3d and 3e displayed good cytotoxic activities with IC 50 values in the range of 7.06-67.46 μM. IC 50 value of 5...

Full description

Saved in:
Bibliographic Details
Published inArchives of physiology and biochemistry Vol. 124; no. 1; pp. 61 - 68
Main Authors Kocyigit, Umit Muhammet, Budak, Yakup, Gürdere, Meliha Burcu, Ertürk, Fatih, Yencilek, Belkız, Taslimi, Parham, Gülçin, İlhami, Ceylan, Mustafa
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 01.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The new 1-(4-(3-(aryl)acryloyl)phenyl)-1H-pyrrole-2,5-diones (5a-g) were prepared from 4′-aminchalcones (3a-g) and screened for biological activities. All compounds (3a-g and 5a-g), except 3d and 3e displayed good cytotoxic activities with IC 50 values in the range of 7.06-67.46 μM. IC 50 value of 5-fluorouracil (5-FU) was 90.36 μM. Moreover, most of compounds 5a-g showed high antibacterial activity with 8-20 mm of inhibition zone (19-25 mm of Sulbactam-Cefoperazone (SCF)). In addition, they showed good inhibitory action against acetylcholinesterase (AChE), and human carbonic anhydrase I, and II (hCA I and hCA II) isoforms. Also, these compounds demonstrated effective inhibition profiles with Ki values of 426.47-699.58 nM against hCA I, 214.92-532.21 nM against hCA II, and 70.470-229.42 nM against AChE. On the other hand, acetazolamide, clinically used drug, showed a Ki value of 977.77 ± 227.4 nM against CA I, and 904.47 ± 106.3 nM against CA II, respectively. Also, tacrine inhibited AChE showed a Ki value of 446.56 ± 58.33 nM.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1381-3455
1744-4160
1744-4160
DOI:10.1080/13813455.2017.1360914